Literature DB >> 24439795

Variations in the open market costs for prostate cancer surgery: a survey of US hospitals.

Scott C Pate1, Matthew A Uhlman1, Jaime A Rosenthal2, Peter Cram2, Bradley A Erickson3.   

Abstract

OBJECTIVE: To examine variation in the open market cost of a radical prostatectomy (RP) procedure in the US hospitals for an uninsured patient, as many proposals for health care reform highlight the importance of individuals actively participating in selecting care. However, reports suggest that obtaining procedure prices remains challenging and highly variable.
MATERIALS AND METHODS: We used 2011-2012 US News and World Report rankings to identify a cohort of 100 hospitals making an effort to include an equal distribution of both academic and private centers, city size, and geographic region. Each hospital was called and the essence of the script included a caller stating he was a healthy, uninsured 55-year-old man recently diagnosed with Gleason 3 + 4 prostatic adenocarcinoma with no metastases. Facility, surgeon, and anesthesia fees were solicited.
RESULTS: Seventy hospitals provided facility prices. Facility estimates averaged $34,720 (±20,335; range, $10,100-$135,000), which was statistically higher at academics centers. No significant differences were seen by region, population, or hospital ranking. Surgeon and anesthesia fees were provided by 10%, averaging $8280 (±$4282; range, $4028-$18,720). Thirty-three hospitals provided discounted fees for prompt payment averaging 34% (±16%; range, 10%-80%).
CONCLUSION: There is wide variation in pricing for RP, with higher rates found in academic centers. Wide variation in facility costs were observed, and nearly all were unable to provide surgeon and/or anesthesia fees. Currently, it appears to be unacceptably difficult for men with prostate cancer without insurance to obtain prices for an RP procedure.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24439795     DOI: 10.1016/j.urology.2013.09.066

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  CORR Insights(®): Time-driven Activity-based Costing More Accurately Reflects Costs in Arthroplasty Surgery.

Authors:  Peter Cram
Journal:  Clin Orthop Relat Res       Date:  2015-05-27       Impact factor: 4.176

2.  Price Transparency in Primary Care: Can Patients Learn About Costs When Scheduling an Appointment?

Authors:  Brendan Saloner; Lisa Clemans Cope; Katherine Hempstead; Karin V Rhodes; Daniel Polsky; Genevieve M Kenney
Journal:  J Gen Intern Med       Date:  2017-02-06       Impact factor: 5.128

3.  Bundled Payments for Elective Primary Total Knee Arthroplasty: An Analysis of Medicare Administrative Data.

Authors:  Peter Cram; Xin Lu; Yue Li
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-03

Review 4.  Financial toxicity associated with treatment of localized prostate cancer.

Authors:  Brandon S Imber; Melissa Varghese; Behfar Ehdaie; Daniel Gorovets
Journal:  Nat Rev Urol       Date:  2019-12-02       Impact factor: 14.432

5.  Is there variation in private payor payments to cancer surgeons? A cross-sectional study in the USA.

Authors:  Tasce Bongiovanni; Simon P Kim; Anthony Kim; Brigid Killelea; Cary Gross
Journal:  BMJ Open       Date:  2020-10-05       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.